Who owns PHARMACYTE BIOTECH INC?
- Ticker: PMCB
- CUSIP Number: 71715x203
Tip: Access positions for across all investors
Analyze quarterly positions in Pharmacyte Biotech with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Pharmacyte Biotech stock
Who bought or sold PHARMACYTE BIOTECH INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Geode Capital Management | 127k | $123k | 0% | Sep 2025 |
|
| Equitec Proprietary Markets | 83k | $80k | 0% | Sep 2025 |
|
| Renaissance Technologies | 80k | $78k | 61% | Sep 2025 |
|
| Vanguard Group | 75k | $73k | -61% | Sep 2025 |
|
| Schonfeld Strategic Advisors | 26k | $25k | 0% | Sep 2025 |
|
| Citadel Advisors | 25k | $24k | 100% | Sep 2025 |
|
| Northern Trust | 19k | $19k | 0% | Sep 2025 |
|
| Tower Research Capital | 5.6k | $5.4k | 99% | Sep 2025 |
|
| UBS Group | 1.3k | $1.3k | -94% | Sep 2025 |
|
| Simplex Trading | 1.1k | $1.0k | 100% | Sep 2025 |
|
| Advisor Group Holdings | 304.00 | $304.000000 | 0% | Sep 2025 |
|
| Covestor | 275.00 | $0 | 0% | Sep 2025 |
|
| Accredited Wealth Management | 50.00 | $1.000000 | 100% | Sep 2025 |
|
| Sachetta | 14.00 | $14.000000 | 0% | Sep 2025 |
|
| BFSG | 5.00 | $5.000000 | 0% | Sep 2025 |
|
| Financial Consulate | 2.00 | $2.000000 | 100% | Sep 2025 |
|
| Goss Wealth Management | 2.00 | $2.000000 | 0% | Sep 2025 |
|
| CWM | 1.00 | $0 | 0% | Sep 2025 |
|
| BlackRock | 1.00 | $1.000000 | 100% | Sep 2025 |
|
| IFP Advisors | 1.00 | $1.000000 | 0% | Sep 2025 |
|
| Morgan Stanley | 1.00 | $1.000000 | 100% | Jun 2025 |
|
Who sold out of Pharmacyte Biotech?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Susquehanna International | Jun 2025 | 28k | $30k |
| Dimensional Fund Advisors | Jun 2025 | 20k | $22k |
| National Bank Of Canada /fi/ | Jun 2025 | 3.3k | $3.6k |
| Raymond James Financial | Jun 2025 | 44.00 | $47.665200 |
| Park Square Financial Group | Jun 2025 | 37.00 | $40.000700 |
| Jpmorgan Chase & Co | Mar 2025 | 16.00 | $20.000000 |
| Koesten, Hirschmann & Crabtree | Jun 2025 | 1.00 | $2.000000 |